Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients

J Hepatol. 2010 Feb;52(2):306-7. doi: 10.1016/j.jhep.2009.10.028. Epub 2009 Nov 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Female
  • HIV Infections / complications*
  • Hepatitis C / complications*
  • Hepatitis C / drug therapy*
  • Hepatitis C / virology
  • Humans
  • Insulin Resistance
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins
  • Retrospective Studies
  • Ribavirin / therapeutic use*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a